In the intricate realm of neuroscience, neurodegenerative diseases stand as formidable adversaries, relentlessly eroding cognitive function and mobility. At Southern Research, we are committed to providing comprehensive preclinical neurodegenerative disease services, empowering researchers to unravel the complexities of these diseases and pave the way for groundbreaking therapies.
Our Expertise: Your Guiding Light in Neurodegenerative Disease Research
Our team of seasoned neuroscientists, neurologists, and molecular biologists possesses extensive experience in understanding the pathogenesis, progression, and potential therapeutic targets of a wide range of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. We are well-versed in a variety of in vitro and in vivo neurodegenerative disease assays, capable of evaluating the efficacy, safety, and pharmacokinetic properties of potential therapeutic compounds and cellular therapies.
Comprehensive Services Spanning the Neurodegenerative Disease Spectrum
We offer a comprehensive suite of preclinical neurodegenerative disease services tailored to address the diverse challenges posed by these diseases:
Neuroprotective and Disease-Modifying Compound Screening and Optimization: We utilize a range of in vitro and in vivo screening assays to identify promising neuroprotective and disease-modifying compounds, optimizing their potency, selectivity, and safety profile.
Pharmacokinetic and Pharmacodynamic (PK/PD) Studies: We determine the absorption, distribution, metabolism, and excretion (ADME) properties of potential therapeutic compounds, providing valuable insights into their pharmacokinetic profiles and pharmacodynamic effects in the central nervous system (CNS).
Regulatory Support and IND Preparation: We guide you through the intricate regulatory landscape, ensuring compliance with FDA guidelines and facilitating the preparation of Investigational New Drug (IND) applications.
